자궁경부암 진단 테스트 시장 조사 – 규모, 점유율, 개발 및 미래 범위 2031

  • Report Code : TIPRE00016639
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 160
Buy Now

자궁경부암 진단 테스트 시장은 2021년 51억 4,125만 달러에서 2028년 71억 6,592만 달러에 이를 것으로 예상됩니다. 2021년부터 2028년까지 CAGR 4.9%로 성장할 것으로 예상됩니다.



자궁경부암은 상당한 사망률(거의 50%)을 갖고 있으며 조기 발견 및 예방으로 낮출 수 있습니다. 전암성 변화는 종종 질병 진행이 지연되기 때문에 예방 및 치료의 기회를 제공합니다. 그러나 진단 서비스에 대한 인식이나 접근 부족으로 인해 많은 사례가 질병 진행의 후기 단계에서 발견됩니다. 인유두종 바이러스(HPV)는 일반적으로 성적 접촉을 통해 전염되는 자궁경부암의 주요 원인입니다. 100개 이상의 HPV 변종이 있으며 그 중 13개는 고위험 또는 발암성입니다. 활성 유전자(E6 또는 E7)는 HPV 변종이 고위험인지 저위험인지를 결정합니다. E6은 p53에 결합하여 단백질 분해를 일으킵니다. 반면에 E7은 망막모세포종에 결합합니다. 결합은 이전에 부착된 전사 인자를 대체하여 세포 주기를 중단시키고 세포 사멸 조절을 억제합니다. HPV 검사는 자궁경부 세포에서 인유두종바이러스를 검출합니다. 개발도상국의 자원이 부족한 지역에서 사용되는 다른 선별 방법은 HPV DNA 검사와 육안 검사입니다. 정기적인 자궁경부 검진은 자궁경부암의 조기 발견을 돕고 질병으로 인한 사망률을 낮춥니다. 3년마다 21세에서 65세 사이의 모든 여성은 팹 테스트를 받고 30세에서 65세 사이의 여성은 팹 테스트와 HPV 테스트를 모두 받도록 권장됩니다. 수익 측면에서 이 유형은 2021년 자궁경부암 검진 시장을 지배했으며 예측 기간 동안 계속 지배적일 것으로 예상됩니다.



전략적 통찰력



자궁경부암의 수익성 있는 지역 진단 테스트 시장



시장 통찰력예측 기간 동안 자궁경부암 진단 테스트 시장 성장을 주도하는 암 유병률 증가



암은 전 세계적으로 주요 사망 원인으로 부상했습니다. 세계보건기구(WHO)에 따르면 암은 2019년 기준 183개국에서 70세 미만 인구의 주요 사망 원인 1위, 전 세계 123개국에서 4위 사망 원인이었다. 2021년 3월 WHO는 다양한 암 유형으로 인해 2020년에 약 천만 명의 사망이 발생했습니다. 전 세계 여성들 사이에서 자궁경부암 발병률이 증가함에 따라 자궁경부암 진단 테스트 시장이 성장하고 있습니다. WHO에 따르면 매년 270,000명 이상의 여성이 자궁경부암으로 사망한다고 합니다. 자궁경부암 사망률은 늦은 진단으로 인해 저소득 국가에서 더 높습니다. 시장은 질병의 조기 발견을 위한 자궁경부암 진단 테스트의 수용 증가로 인해 향후 몇 년 동안 성장할 것으로 예상됩니다. 증가하는 암 유병률은 전 세계 의료 시스템에 부담을 주었습니다. 국제암연구소(International Agency for Research on Cancer, IARC)에 따르면 2040년까지 새로운 암 사례의 세계적 부담은 ~2,750만 명에 이를 것으로 추정되며, 그 질병은 그 해까지 ~1억 6,300만 명의 사망 원인이 될 가능성이 높습니다. 생활 방식 변화, 흡연, 신체 활동 감소, 불확실한 건강 및 기후 조건과 같은 요인으로 인해 향후 몇 년 동안 전 세계에서 암 부담이 훨씬 더 커질 것입니다.



유형 기반 통찰력



자궁경부암 진단 테스트 시장은 유형에 따라 PAP 테스트, HPV 테스트, 질 확대경 검사, 자궁경부 생검, 방광경 검사 등으로 분류됩니다. 2021년에 PAP 테스트 부문은 시장에서 가장 큰 점유율을 차지했으며 2021-2028년 동안 가장 높은 CAGR을 등록할 것으로 추정됩니다.



자궁경부암 진단 테스트 시장, 유형별 – 2021 및 2028



h3>

서비스 제공자 기반 통찰력



서비스 제공자를 기반으로 시장은 연구, 진단 및 연구 실험실, 병원 및 진료소, 전문 진료소 및 재택 간호 서비스로 분류됩니다. 2021년 진단 및 연구 실험실 부문은 시장에서 가장 큰 점유율을 차지했으며 2021-2028년 동안 시장에서 가장 높은 CAGR을 등록할 것으로 예상됩니다. 자궁경부암 진단 테스트 시장에서 운영하는 회사는 제품 혁신과 같은 다양한 전략을 채택하고 있습니다. , 전 세계적으로 진화하는 고객 요구를 충족하고 글로벌 시장에서 브랜드 이름을 유지합니다.



자궁경부암 진단 테스트 시장 – 세분화



자궁경부암 진단 테스트 시장은 다음을 기준으로 세분화됩니다. 유형의 기초 및 서비스 제공자. 유형에 따라 시장은 PAP 테스트, HPV 테스트, 질 확대경 검사, 자궁경부 생검, 방광경 검사 등으로 세분화됩니다. 서비스 제공자를 기반으로 시장은 진단 및 연구 실험실, 병원 및 진료소, 전문 진료소 및 재택 간호 서비스로 세분화됩니다. 지리적으로 자궁경부암 진단 테스트 시장은 북미(미국, 캐나다 및 멕시코), 유럽(프랑스, 독일, 이탈리아, 영국, 스페인 및 기타 유럽), 아시아 태평양(호주, 중국, 인도, 일본, 대한민국 및 나머지 APAC), 중동 및 아프리카(사우디아라비아, 남아프리카, UAE 및 기타 MEA), 중남미(브라질, 아르헨티나 및 기타 SCAM) ).



회사 프로필





  • F. Hoffmann-La Roche Ltd.

  • Abbott

  • Quest Diagnostics Incorporated

  • QIAGEN

  • Hologic, Inc.

  • DYSIS Medical Inc.

  • Femasys Inc.

  • Guided Therapeutics, Inc.

  • Cooper Companies, Inc.

  • BD


Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is Cervical Cancer Diagnostic Testing?

Cervical Cancer refers to cancer that occurs in the cells of the cervix i.e. the lower part of the uterus that connects to the vagina. In 90% of the cases, cervical malignancies occur due to the HPV infection and are diagnosed through smear screening.

What are the factors impacting the cervical cancer diagnostic testing market?

The factors that are driving and restraining factors that will affect the cervical cancer diagnostic testing market in the coming years. Factors such as the increasing prevalence of cancer and the rise in HPV infections are driving the market growth. However, less number of commercially available vaccines for the treatment of cancer are likely to hamper the growth of the market.

Who are the major players in the cervical cancer diagnostic testing market?

The cervical cancer diagnostic testing market majorly consists of the players such as as F. Hoffmann-La Roche Ltd., Abbott, Quest Diagnostics Incorporated, QIAGEN, Hologic, Inc., DYSIS Medical Inc., Femasys Inc., Guided Therapeutics, Inc, Cooper Companies, Inc., BD are amongst others.

What is the market value of the cervical cancer diagnostic testing market based on region?

The global cervical cancer diagnostic testing market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. The North American area holds the largest market for aesthetic skin devices. The United States held the most significant cervical cancer diagnostic testing market and is expected to grow due to factors such as high awareness about disease prevention among women in the region, as well as to the many initiatives launched to prevent cervical cancer, which have increased the reach of insurance coverage for cervical screening tests, especially for low-income women, and others.

Which is the most influencing segment growing in the cervical cancer diagnostic testing market report?

The cervical cancer diagnostic testing market based on type is segmented into PAP testing, HPV testing, colposcopy, cervical biopsies, cystoscopy, others. In 2021, the PAP Testing segment accounted for the highest share. Besides, the HPV testing segment is expected to grow at a CAGR of 5.5% in the forecast period.

Which region is expected to witness significant demand for the cervical cancer diagnostic testing market in the coming years?

Asia Pacific is registered as the fastest-growing region in the global cervical cancer diagnostic testing market. The market is this region is expected to grow significantly in countries such as China, Japan, and India. The market is driven by the increasing prevalence of cervical cancer in developing countries, including China, India, Malaysia, Japan, South Korea, and Australia.

The List of Companies - Cervical Cancer Diagnostic Testing Market

  1. F. HOFFMANN-LA ROCHE LTD.
  2. Abbott
  3. Quest Diagnostics Incorporated
  4. QIAGEN
  5. Hologic, Inc.
  6. DYSIS Medical Inc
  7. Femasys Inc.
  8. GUIDED THERAPEUTICS, INC
  9. Cooper Companies, Inc.
  10. BD

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports